Status:
UNKNOWN
Communicational Program "Trust" to Improve Adherence to Medications
Lead Sponsor:
Meshalkin Research Institute of Pathology of Circulation
Conditions:
Coronary Artery Disease
Myocardial Infarction
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The trial was designed in such a way as to show that the proposed program "Trust" increases the proportion of patients who adhere to therapy in the cohort of those with coronary heart disease for two ...
Detailed Description
The "Trust" program includes a set of measures aimed at increasing the level of adherence to therapy in patients with myocardial infarction. Differences in adherence rates between patients enrolled in...
Eligibility Criteria
Inclusion
- Signed informed consent
- Recent acute myocardial infarction within the past 2 months
- Successful revascularization via coronary stenting or thrombolysis
Exclusion
- Concomitant cardiovascular disorders requiring surgical treatment
- Coronary revascularization via CABG
- Patient refused from participating
- Patient is not available for communication within 2 months
Key Trial Info
Start Date :
March 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2020
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT03268291
Start Date
March 1 2017
End Date
December 30 2020
Last Update
August 31 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
State Research Institute of CIrculation Pathology
Novosibirsk, Russia, 630055